Safety and efficacy of readministration of infliximab after longterm continuous therapy and withdrawal in patients with ankylosing spondylitis.
Baraliakos X, Listing J, Rudwaleit M, Brandt J, Alten R, Burmester G, Gromnica-Ihle E, Haibel H, Schewe S, Schneider M, Sörensen H, Zeidler H, Visvanathan S, Sieper J, Braun J.
Baraliakos X, et al. Among authors: haibel h.
J Rheumatol. 2007 Mar;34(3):510-5. Epub 2007 Feb 1.
J Rheumatol. 2007.
PMID: 17299842
Clinical Trial.